All Press Releases
医思健康与保诚香港达成战略合作
EC Healthcare
•
Feb 13, 2023 19:11 HKT/SGT
香港最大非医院医疗服务机构*──医思健康（「公司」，连同附属公司，总称「集团」；香港联交所股份编号：2138）欣然宣布，集团与保诚保险有限公司（「保诚」）达成战略合作关系，双方将共同开发定制化的健康管理增值服务，守护客户的健康及财富。基于双方的战略合作，医思健康将作为专属服务供应商，向保诚的客户提供复必泰二价疫苗注射及其他医疗服务，保诚香港客户可透过网上平台进行预约。医思健康致力构建一站式多专科大健康服务闭环平台，与保险巨头的合作是公司核心策略的重要组成部分。得益于多年来建立的领先品牌及透过独特的一站式大健康生态提供的全面健康管理服务，集团与保险巨头建立了互信的合作关系，不断完善可实现产业链纵
醫思健康與保誠香港達成戰略合作
EC Healthcare
•
Feb 13, 2023 19:10 HKT/SGT
香港最大非醫院醫療服務機構*──醫思健康（「公司」，連同附屬公司，總稱「集團」；香港聯交所股份編號：2138）欣然宣佈，集團與保誠保險有限公司（「保誠」）達成戰略合作關係，雙方將共同開發定制化的健康管理增值服務，守護客戶的健康及財富。基於雙方的戰略合作，醫思健康將作為專屬服務供應商，向保誠的客戶提供復必泰二價疫苗注射及其他醫療服務，保誠香港客戶可透過網上平台進行預約。醫思健康致力構建一站式多專科大健康服務閉環平台，與保險巨頭的合作是公司核心策略的重要組成部分。得益於多年來建立的領先品牌及透過獨特的一站式大健康生態提供的全面健康管理服務，集團與保險巨頭建立了互信的合作關係，不斷完善可實現產業鏈縱
EC Healthcare Announced Strategic Alliance with Prudential
EC Healthcare
•
Feb 13, 2023 19:09 HKT/SGT
EC Healthcare (the "Company", which together with its subsidiaries is referred to as the "Group", SEHK stock code: 2138), the largest non-hospital medical group in Hong Kong*, is pleased to announce that the Group formed partnership with Prudential Hong Kong Limited ("Pruden
Blockchain Life will host the 10th Global Blockchain and Crypto Forum in Dubai
ACN Newswire
•
Feb 13, 2023 08:00 HKT/SGT
The 10th Global Forum on blockchain, cryptocurrencies and mining -- Blockchain Life 2023 takes place on February 27-28 in Dubai. The event is attended by key industry players, government representatives, heads of international companies and funds, investors, promising startups teams and beginners. I
노보텍 글로벌 보고서: 아시아 태평양 지역에서 1단계 임상시험의 확고한 성장
Novotech Health Holdings Pte Ltd
•
Feb 13, 2023 06:00 HKT/SGT
아시아 태평양 지역의 선도적인 생명공학 전문 임상시험수탁기관(CRO)인 노보텍은 빠른 성장 지역과 치료 분야에 대한 최신 지표를 포함하여 1단계 임상시험 활동에 대한 글로벌 보고서를 새로 발표했습니다. 데이터 분석 결과에 따르면 아시아 태평양 지역은 지난 10년 동안 1단계 임상시험에서 가장 빠르게 성장한 지역으로, 2022년에는 58%의 점유율에 도달했으며 중국이 전 세계적으로 1단계 시험을 주도하고 있습니다.노보텍은 고품질의 신속한 임상시험을 제공하면서 명성을 쌓아온 아시아 태평양 지역에 전문적으로 집중하는 것과 함께 생명공학
Novotech 全球報告：亞太地區穩健的 1 期試驗增長
Novotech Health Holdings Pte Ltd
•
Feb 13, 2023 06:00 HKT/SGT
以亞太地區為中心的領先生物技術 CRO Novotech 發布了一份關於 Phase 1 試驗活動的新全球報告，包括快速增長區域和治療領域的當前指標。數據分析發現，亞太地區是過去十年中 1 期試驗增長最快的地區，到 2022 年達到 58% 的份額，其中中國在全球領先 1 期試驗。Novotech 在歐洲和美國提供獨特且無與倫比的早期至晚期 CRO 服務套件，並專注於亞太地區，該公司在提供高質量的快速臨床試驗方面享有盛譽。根據題為“I期全球臨床試驗格局——聚焦亞太地區”的新報告，2022 年亞太地區佔全球啟動的約 3,600 項 I 期試驗的 58%。該報告發現，亞太地區是過去十年中 1 期試
Novotech 全球报告：亚太地区稳健的 1 期试验增长
Novotech Health Holdings Pte Ltd
•
Feb 13, 2023 06:00 HKT/SGT
以亚太地区为中心的领先生物技术 CRO Novotech 发布了一份关于 Phase 1 试验活动的新全球报告，包括快速增长区域和治疗领域的当前指标。 数据分析发现，亚太地区是过去十年中 1 期试验增长最快的地区，到 2022 年达到 58% 的份额，其中中国在全球领先 1 期试验。Novotech 在欧洲和美国提供独特且无与伦比的早期至晚期 CRO 服务套件，并专注于亚太地区，该公司在提供高质量的快速临床试验方面享有盛誉。根据题为“I期全球临床试验格局——聚焦亚太地区”的新报告，2022 年亚太地区占全球启动的约 3,600 项 I 期试验的 58%。 该报告发现，亚太地区是过去十年中 1
Korindo Transfers Urban Forest Management to Bogor Regency Government
Korindo
•
Feb 11, 2023 01:00 HKT/SGT
After three years of planting and maintenance under Korindo Foundation's care, Pakansari Stadium's urban forest (or Pakansari City Forest) was finally handed over to the Bogor Regency Government at the beginning of February 2023. Korindo Foundation Chairman Robert Seung performed the handi
First Patient in the US Dosed in a Global Multicentre Phase 3 Clinical Study of Bevacizumab for treatment of Ophthalmic Diseases
Essex Bio-Technology Limited
•
Feb 10, 2023 21:06 HKT/SGT
Essex Bio-Technology Ltd ("Essex" or the "Group", 1061.HK) today announced that the first patient in the United States (US) was dosed in a global multi-centre phase 3 clinical trial (NCT04740671) of EB12-20145P (HLX04-O), a recombinant anti-VEGF humanised monoclonal antibody inje
亿胜生物宣布贝伐珠单抗眼科适应症国际多中心III期临床研究完成美国首例患者给药
Essex Bio-Technology Limited
•
Feb 10, 2023 20:39 HKT/SGT
亿胜生物科技有限公司（“亿胜生物”或“集团”，股票代码：1061.HK）今日宣布，集团与上海复宏汉霖生物技术股份有限公司（“复宏汉霖”，股票代码：2696.HK）合作开发重组抗血管内皮生长因子（Vascular endothelial growth factor，VEGF）人源化单克隆抗体注射液EB12-20145P（HLX04-O）的国际多中心III期临床研究（NCT04740671）完成美国首例患者给药，拟用于湿性年龄相关性黄斑变性（wet age-related macular degeneration, wAMD）的治疗。该临床研究此前已在澳大利亚和欧盟完成首例患者给药。另一项在wAM
億勝生物宣佈貝伐珠單抗眼科適應症國際多中心III期臨床研究完成美國首例患者給藥
Essex Bio-Technology Limited
•
Feb 10, 2023 20:38 HKT/SGT
億勝生物科技有限公司（「億勝生物」或「集團」，股票代碼：1061.HK）今日宣佈，集團與上海復宏漢霖生物技術股份有限公司（「復宏漢霖」，股票代碼：2696.HK）合作開發重組抗血管內皮生長因子（Vascular endothelial growth factor，VEGF）人源化單克隆抗體注射液EB12-20145P（HLX04-O）的國際多中心III期臨床研究（NCT04740671）完成美國首例患者給葯，擬用於濕性年齡相關性黃斑變性（wet age-related macular degeneration, wAMD）的治療。該臨床研究此前已在澳大利亞和歐盟完成首例患者給藥。另一項在wAM
XOX Strengthens Presence in Local Football Scene with KLCFC Partnership
XOX Bhd
•
Feb 10, 2023 19:00 HKT/SGT
XOX Berhad (XOX), via its sports marketing arm, XOX Pro Sport Sdn. Bhd., and the Kuala Lumpur City Football Club (KLCFC) have kick-started a partnership to offer XOX's comprehensive range of product and service to the public. The companies in XOX's ecosystem range from technology offerings
Novotech Global Report: Robust Phase 1 Trial Growth Across Asia Pacific
Novotech Health Holdings Pte Ltd
•
Feb 10, 2023 19:00 HKT/SGT
Novotech, the leading Asia Pacific centred biotech CRO, has published a new global report on Phase 1 trial activity including current metrics on fast growth regions and therapeutic areas. The data analysis found that Asia Pacific has been the fastest-growing region for Phase 1 trials in the last ten
Bintai Kinden Wins RM14.2 Million Project from TNB
Bintai Kinden Corporation Bhd
•
Feb 10, 2023 18:00 HKT/SGT
Bintai Kinden Corporation Bhd (Bursa: BINTAI, 6998), a mechanical and electrical (M&E) engineering services specialist, is pleased to announce that the Company's wholly-owned subsidiary, Kejuruteraan Bintai Kindenko Sdn Bhd (KBK), has been awarded a project worth RM14.2 million by Tenaga Na
百果园年货节成绩亮眼：全渠道终端零售额超13亿元，三四线市场消费升级明显
Pagoda
•
Feb 10, 2023 17:07 HKT/SGT
每年春节前后，各大商家都会围绕年货进行营销，国内水果连锁零售龙头企业百果园，也一直坚持“春节不打烊”传统，水果蔬菜备货充足，全面满足消费者春节期间的饮食和送礼需求。据悉，百果园年货节（2023年1月3日至2月5日）期间，全渠道终端零售额超过13亿元。与往年春节不同的是，随着2022年底疫情管控放开，国人返乡热情高涨，今年春节送礼需求增势明显。百果园年货节期间，水果礼盒装总销量超134万个，贡献金额超3亿元，同比增长 21.4%。三四线下沉市场数据表现尤为突出：年货节期间，百果园销售TOP10城市中，三四线城市占据约60%。为了满足消费者更便捷、更个性化地购买，百果园针对顾客需求定制了不同的春节
百果園年貨節成績亮眼：全渠道終端零售額超13億元，三四線市場消費升級明顯
Pagoda
•
Feb 10, 2023 17:06 HKT/SGT
每年春節前後，各大商家都會圍繞年貨進行營銷，國內水果連鎖零售龍頭企業百果園，也一直堅持“春節不打烊”傳統，水果蔬菜備貨充足，全面滿足消費者春節期間的飲食和送禮需求。據悉，百果園年貨節（2023年1月3日至2月5日）期間，全渠道終端零售額超過13億元。與往年春節不同的是，隨著2022年底疫情管控放開，國人返鄉熱情高漲，今年春節送禮需求增勢明顯。百果園年貨節期間，水果禮盒裝總銷量超134萬個，貢獻金額超3億元，同比增長 21.4%。三四線下沉市場資料表現尤為突出：年貨節期間，百果園銷售TOP10城市中，三四線城市佔據約60%。為了滿足消費者更便捷、更個性化地購買，百果園針對顧客需求定制了不同的春節
Infocus International Brings Back Renewable Energy Project Finance & Financial Modelling Masterclass
ACN Newswire
•
Feb 10, 2023 16:07 HKT/SGT
Infocus International Group is bringing back the Renewable Energy Project Finance & Financial Modelling online masterclass and it will be commencing live on the 7th March 2023. The objective of this course is to provide participants with an enhanced understanding of the financial modelling and k
Hong Kong's Middle East mission lays groundwork for new business opportunities
HKTDC
•
Feb 10, 2023 13:00 HKT/SGT
Since the recent reopening of the Hong Kong-mainland border, the Hong Kong Trade Development Council (HKTDC) embarked on a week-long business mission to the Middle East, led by Mr John Lee, Chief Executive of the Hong Kong Special Administrative Region (HKSAR).Mr Lee was accompanied by principal off
Former Singapore Parliamentarian's Swiss Digital Assets Company Receives Regulatory Approval
ACN Newswire
•
Feb 10, 2023 10:45 HKT/SGT
Calvin Cheng's Damoon Technologies has obtained membership status from the Swiss Financial Services Standard Association ('VQF'), which is officially recognised by the Federal Financial Market Supervisory Authority ('FINMA') This comes on the back of Cheng's Web3 Company obtaining the V
FBS Celebrates Its 14th Birthday, Inviting Traders to Join Their Big Promo Event
ACN Newswire
•
Feb 09, 2023 22:00 HKT/SGT
New York, NY, Feb 9, 2023 - (ACN Newswire) - FBS, a licensed world Forex broker, is excited to invite its traders to join in the celebration of its 14th birthday with the FBS Ultimate Trading Birthday promo. The event offers the chance to win big prizes, including the grand prize of a luxury car.